Journal article
Insights into mucopolysaccharidosis I from the structure and action of α-L-iduronidase
H Bie, J Yin, X He, AR Kermode, ED Goddard-Borger, SG Withers, MNG James
Nature Chemical Biology | Published : 2013
Abstract
Mucopolysaccharidosis type I (MPS I), caused by mutations in the gene encoding α-L-iduronidase (IDUA), is one of approximately 70 genetic disorders collectively known as the lysosomal storage diseases. To gain insight into the basis for MPS I, we crystallized human IDUA produced in an Arabidopsis thaliana cgl mutant. IDUA consists of a TIM barrel domain containing the catalytic site, a β-sandwich domain and a fibronectin-like domain. Structures of IDUA bound to iduronate analogs illustrate the Michaelis complex and reveal a 2,5 B conformation in the glycosyl-enzyme intermediate, which suggest a retaining double displacement reaction involving the nucleophilic Glu299 and the general acid/base..
View full abstractGrants
Awarded by Alberta Innovates - Health Solutions
Funding Acknowledgements
This paper is dedicated to the memory of John Colter (1923-2013), chair of the Department of Biochemistry, University of Alberta, from 1961 to 1987. We thank S. Khan for his technical assistance during in-house data collection and the staff at the Canadian Light Source in Saskatoon and the Stanford Synchrotron Radiation Lightsource for their assistance in the data collection. We are grateful for the initial work done by K. Bateman on the growth of the monoclinic form of IDUA crystals, for synthetic work performed by A. Wong and for the expression and purification of CBM-PNGase-F by E. Kwan. We also thank J. Hopwood for the monoclonal antibody to human IDUA. M.N.G. J. and A.R.K. are grateful for the funding support from the Canadian Institutes for Health Research (grant no. MOP123222). H.B. thanks Alberta Innovates Health Solution for the fellowship support. E.D.G.-B. thanks the Canadian Institute of Health Research for a postdoctoral fellowship. A.R.K. is grateful for funding support from the Canadian Society for Mucopolysaccharide and Related Diseases and to the Michael Smith Foundation for Health Research for the Senior Scholar Award (award no. CI-SSH-01915(07-1)).